Melanie Herman
Head of Investor Relations
Replay available
Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Todd Davis
Chief Executive Officer
Octavio Espinoza
Chief Financial Officer
Lauren Haig
Vice President, Portfolio Strategy and Investments
Matt Hewitt
Analyst at Craig-Hallum Capital Group
Annabelle Samimi
Analyst at Stifel
Yigal Nochomovitz
Analyst at Citigroup
Leland Gershel
Analyst at Oppenheimer & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ligand Pharmaceuticals Incorporated.
Replay transcript excerpt
WEBVTT 00:00:01.367 -- 00:00:06.509 Hello, everyone. Thank you for joining us and welcome to the Ligand Second Quarter 00:00:06.509 -- 00:00:11.751 2026 Earnings Call. After today's prepared remarks, we will host 00:00:11.751 -- 00:00:17.193 a question and answer session. If you would like to ask a question, please press 00:00:17.193 -- 00:00:22.474 star 1 to raise your hand. To withdraw your question, press 00:00:22.474 -- 00:00:24.883 star 1 again. 00:00:24.883 -- 00:00:30.508 I will now hand the conference over to Melanie Herman, Head of Investor Relations. 00:00:30.508 -- 00:00:33.669 Melanie, please go ahead. 00:00:35.091 -- 00:00:39.955 Good morning, everyone, and welcome to Ligand's second quarter 2026 earnings call. 00:00:39.955 -- 00:00:45.099 With me on the call today are CEO Todd Davis, Chief Financial Officer Octavio Espinoza, 00:00:45.099 -- 00:00:49.174 and Vice President of Portfolio Strategy and Investments, Lauren Haig. 00:00:49.174 -- 00:00:53.017 During the call today, we will review the financial results released earlier today and 00:00:53.017 -- 00:00:57.681 provide commentary on our partner portfolio and business development activity, followed 00:00:57.681 -- 00:01:01.864 by a question and answer session. Before we get started, I would like to point out we 00:01:01.864 -- 00:01:06.248 will be discussing non-GAAP results, which exclude certain items such as stock-based 00:01:06.248 -- 00:01:11.312 compensation, amortization of intangible assets, amortization or impairment of financial 00:01:11.312 -- 00:01:16.562 assets, and gains or losses from derivative assets, amongst others. 00:01:16.562 -- 00:01:20.124 I encourage you to review the reconciliation of these non-GAAP measures to their most 00:01:20.124 -- 00:01:24.347 directly comparable GAAP ...